nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS1—kidney cancer	0.283	0.636	CbGaD
Mefenamic acid—PTGS2—kidney cancer	0.162	0.364	CbGaD
Mefenamic acid—AKR1C3—Doxorubicin—kidney cancer	0.148	0.495	CbGbCtD
Mefenamic acid—CYP2C8—Pazopanib—kidney cancer	0.0333	0.111	CbGbCtD
Mefenamic acid—CYP2C9—Capecitabine—kidney cancer	0.0242	0.0809	CbGbCtD
Mefenamic acid—CYP2C8—Erlotinib—kidney cancer	0.0238	0.0794	CbGbCtD
Mefenamic acid—CYP2C8—Paclitaxel—kidney cancer	0.0218	0.0727	CbGbCtD
Mefenamic acid—CYP2C8—Sorafenib—kidney cancer	0.0193	0.0646	CbGbCtD
Mefenamic acid—CYP2C9—Paclitaxel—kidney cancer	0.0152	0.0507	CbGbCtD
Mefenamic acid—CYP2C9—Sorafenib—kidney cancer	0.0135	0.045	CbGbCtD
Mefenamic acid—AKR1C3—Vincristine—Vinblastine—kidney cancer	0.00177	0.554	CbGdCrCtD
Mefenamic acid—AKR1C3—Vinblastine—Vincristine—kidney cancer	0.00142	0.446	CbGdCrCtD
Mefenamic acid—Acetylsalicylic acid—TP53—kidney cancer	0.000539	0.0934	CrCbGaD
Mefenamic acid—Floctafenine—PTGS1—kidney cancer	0.000485	0.084	CrCbGaD
Mefenamic acid—Lumiracoxib—PTGS1—kidney cancer	0.000313	0.0541	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS1—kidney cancer	0.000313	0.0541	CrCbGaD
Mefenamic acid—Nepafenac—PTGS1—kidney cancer	0.000297	0.0515	CrCbGaD
Mefenamic acid—Niflumic Acid—PTGS1—kidney cancer	0.000279	0.0482	CrCbGaD
Mefenamic acid—Floctafenine—PTGS2—kidney cancer	0.000277	0.048	CrCbGaD
Mefenamic acid—Salsalate—PTGS1—kidney cancer	0.000247	0.0428	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS1—kidney cancer	0.000244	0.0422	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS1—kidney cancer	0.000204	0.0354	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—PTGS1—kidney cancer	0.000185	0.032	CrCbGaD
Mefenamic acid—Lumiracoxib—PTGS2—kidney cancer	0.000179	0.0309	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—kidney cancer	0.000179	0.0309	CrCbGaD
Mefenamic acid—Nepafenac—PTGS2—kidney cancer	0.00017	0.0294	CrCbGaD
Mefenamic acid—Niflumic Acid—PTGS2—kidney cancer	0.000159	0.0276	CrCbGaD
Mefenamic acid—Salicylic acid—PTGS1—kidney cancer	0.000152	0.0263	CrCbGaD
Mefenamic acid—Salsalate—PTGS2—kidney cancer	0.000141	0.0245	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—kidney cancer	0.000139	0.0241	CrCbGaD
Mefenamic acid—Diclofenac—PTGS1—kidney cancer	0.000136	0.0236	CrCbGaD
Mefenamic acid—Flurbiprofen—PTGS1—kidney cancer	0.000133	0.0231	CrCbGaD
Mefenamic acid—Diclofenac—CYP1A1—kidney cancer	0.000124	0.0215	CrCbGaD
Mefenamic acid—Ketoprofen—PTGS1—kidney cancer	0.000121	0.0209	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS2—kidney cancer	0.000117	0.0202	CrCbGaD
Mefenamic acid—Urethral disorder—Capecitabine—kidney cancer	0.000112	0.000611	CcSEcCtD
Mefenamic acid—Renal impairment—Doxorubicin—kidney cancer	0.000112	0.00061	CcSEcCtD
Mefenamic acid—Paraesthesia—Vincristine—kidney cancer	0.000112	0.00061	CcSEcCtD
Mefenamic acid—Rash—Everolimus—kidney cancer	0.000111	0.000606	CcSEcCtD
Mefenamic acid—Dermatitis—Everolimus—kidney cancer	0.000111	0.000605	CcSEcCtD
Mefenamic acid—Headache—Vinblastine—kidney cancer	0.000111	0.000604	CcSEcCtD
Mefenamic acid—Angioedema—Paclitaxel—kidney cancer	0.000111	0.000604	CcSEcCtD
Mefenamic acid—Purpura—Doxorubicin—kidney cancer	0.00011	0.000602	CcSEcCtD
Mefenamic acid—Headache—Everolimus—kidney cancer	0.00011	0.000602	CcSEcCtD
Mefenamic acid—Hypotension—Gemcitabine—kidney cancer	0.00011	0.000602	CcSEcCtD
Mefenamic acid—Body temperature increased—Dactinomycin—kidney cancer	0.00011	0.000601	CcSEcCtD
Mefenamic acid—Abdominal pain—Dactinomycin—kidney cancer	0.00011	0.000601	CcSEcCtD
Mefenamic acid—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00011	0.0006	CcSEcCtD
Mefenamic acid—Asthenia—Sorafenib—kidney cancer	0.00011	0.000599	CcSEcCtD
Mefenamic acid—Malaise—Paclitaxel—kidney cancer	0.000109	0.000596	CcSEcCtD
Mefenamic acid—Vertigo—Paclitaxel—kidney cancer	0.000109	0.000594	CcSEcCtD
Mefenamic acid—Syncope—Paclitaxel—kidney cancer	0.000109	0.000593	CcSEcCtD
Mefenamic acid—Leukopenia—Paclitaxel—kidney cancer	0.000108	0.000591	CcSEcCtD
Mefenamic acid—Decreased appetite—Vincristine—kidney cancer	0.000108	0.00059	CcSEcCtD
Mefenamic acid—Pruritus—Sorafenib—kidney cancer	0.000108	0.00059	CcSEcCtD
Mefenamic acid—Vomiting—Erlotinib—kidney cancer	0.000108	0.00059	CcSEcCtD
Mefenamic acid—Erythema multiforme—Capecitabine—kidney cancer	0.000108	0.000589	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Vincristine—kidney cancer	0.000107	0.000586	CcSEcCtD
Mefenamic acid—Rash—Erlotinib—kidney cancer	0.000107	0.000585	CcSEcCtD
Mefenamic acid—Dermatitis—Erlotinib—kidney cancer	0.000107	0.000584	CcSEcCtD
Mefenamic acid—Palpitations—Paclitaxel—kidney cancer	0.000107	0.000584	CcSEcCtD
Mefenamic acid—Hyponatraemia—Doxorubicin—kidney cancer	0.000107	0.000583	CcSEcCtD
Mefenamic acid—Insomnia—Gemcitabine—kidney cancer	0.000107	0.000583	CcSEcCtD
Mefenamic acid—Headache—Erlotinib—kidney cancer	0.000106	0.000581	CcSEcCtD
Mefenamic acid—Tinnitus—Capecitabine—kidney cancer	0.000106	0.000581	CcSEcCtD
Mefenamic acid—Loss of consciousness—Paclitaxel—kidney cancer	0.000106	0.000581	CcSEcCtD
Mefenamic acid—Constipation—Vincristine—kidney cancer	0.000106	0.000581	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000106	0.00058	CcSEcCtD
Mefenamic acid—Paraesthesia—Gemcitabine—kidney cancer	0.000106	0.000578	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—PTGS2—kidney cancer	0.000105	0.0183	CrCbGaD
Mefenamic acid—Asthenia—Sunitinib—kidney cancer	0.000105	0.000576	CcSEcCtD
Mefenamic acid—Dyspnoea—Gemcitabine—kidney cancer	0.000105	0.000574	CcSEcCtD
Mefenamic acid—Nausea—Vinblastine—kidney cancer	0.000105	0.000573	CcSEcCtD
Mefenamic acid—Somnolence—Gemcitabine—kidney cancer	0.000105	0.000573	CcSEcCtD
Mefenamic acid—Convulsion—Paclitaxel—kidney cancer	0.000105	0.000573	CcSEcCtD
Mefenamic acid—Nausea—Everolimus—kidney cancer	0.000105	0.000571	CcSEcCtD
Mefenamic acid—Diarrhoea—Sorafenib—kidney cancer	0.000105	0.000571	CcSEcCtD
Mefenamic acid—Hypertension—Paclitaxel—kidney cancer	0.000104	0.000571	CcSEcCtD
Mefenamic acid—Pruritus—Sunitinib—kidney cancer	0.000104	0.000568	CcSEcCtD
Mefenamic acid—Anxiety—Paclitaxel—kidney cancer	0.000103	0.000561	CcSEcCtD
Mefenamic acid—Decreased appetite—Gemcitabine—kidney cancer	0.000103	0.00056	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000102	0.000559	CcSEcCtD
Mefenamic acid—Arrhythmia—Capecitabine—kidney cancer	0.000102	0.000556	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000102	0.000556	CcSEcCtD
Mefenamic acid—Discomfort—Paclitaxel—kidney cancer	0.000102	0.000556	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Vincristine—kidney cancer	0.000102	0.000555	CcSEcCtD
Mefenamic acid—Dizziness—Sorafenib—kidney cancer	0.000101	0.000552	CcSEcCtD
Mefenamic acid—Constipation—Gemcitabine—kidney cancer	0.000101	0.000551	CcSEcCtD
Mefenamic acid—Nausea—Erlotinib—kidney cancer	0.000101	0.000551	CcSEcCtD
Mefenamic acid—Alopecia—Capecitabine—kidney cancer	0.000101	0.00055	CcSEcCtD
Mefenamic acid—Dry mouth—Paclitaxel—kidney cancer	0.000101	0.00055	CcSEcCtD
Mefenamic acid—Diarrhoea—Sunitinib—kidney cancer	0.000101	0.000549	CcSEcCtD
Mefenamic acid—Mental disorder—Capecitabine—kidney cancer	9.99e-05	0.000546	CcSEcCtD
Mefenamic acid—Asthenia—Dactinomycin—kidney cancer	9.98e-05	0.000545	CcSEcCtD
Mefenamic acid—Confusional state—Paclitaxel—kidney cancer	9.96e-05	0.000544	CcSEcCtD
Mefenamic acid—PTGS2—nephron—kidney cancer	9.93e-05	0.196	CbGeAlD
Mefenamic acid—Anaphylactic shock—Paclitaxel—kidney cancer	9.87e-05	0.000539	CcSEcCtD
Mefenamic acid—Oedema—Paclitaxel—kidney cancer	9.87e-05	0.000539	CcSEcCtD
Mefenamic acid—Body temperature increased—Vincristine—kidney cancer	9.83e-05	0.000537	CcSEcCtD
Mefenamic acid—Abdominal pain—Vincristine—kidney cancer	9.83e-05	0.000537	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Doxorubicin—kidney cancer	9.81e-05	0.000536	CcSEcCtD
Mefenamic acid—Infection—Paclitaxel—kidney cancer	9.81e-05	0.000536	CcSEcCtD
Mefenamic acid—Flatulence—Capecitabine—kidney cancer	9.78e-05	0.000534	CcSEcCtD
Mefenamic acid—Dizziness—Sunitinib—kidney cancer	9.72e-05	0.000531	CcSEcCtD
Mefenamic acid—Feeling abnormal—Gemcitabine—kidney cancer	9.72e-05	0.000531	CcSEcCtD
Mefenamic acid—Shock—Paclitaxel—kidney cancer	9.71e-05	0.000531	CcSEcCtD
Mefenamic acid—Vomiting—Sorafenib—kidney cancer	9.71e-05	0.00053	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Paclitaxel—kidney cancer	9.67e-05	0.000528	CcSEcCtD
Mefenamic acid—Tachycardia—Paclitaxel—kidney cancer	9.64e-05	0.000526	CcSEcCtD
Mefenamic acid—Rash—Sorafenib—kidney cancer	9.63e-05	0.000526	CcSEcCtD
Mefenamic acid—Dermatitis—Sorafenib—kidney cancer	9.62e-05	0.000526	CcSEcCtD
Mefenamic acid—Skin disorder—Paclitaxel—kidney cancer	9.59e-05	0.000524	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	9.57e-05	0.000523	CcSEcCtD
Mefenamic acid—Headache—Sorafenib—kidney cancer	9.57e-05	0.000523	CcSEcCtD
Mefenamic acid—Diarrhoea—Dactinomycin—kidney cancer	9.52e-05	0.00052	CcSEcCtD
Mefenamic acid—Anorexia—Paclitaxel—kidney cancer	9.41e-05	0.000514	CcSEcCtD
Mefenamic acid—Gastritis—Doxorubicin—kidney cancer	9.41e-05	0.000514	CcSEcCtD
Mefenamic acid—Vision blurred—Capecitabine—kidney cancer	9.36e-05	0.000511	CcSEcCtD
Mefenamic acid—Vomiting—Sunitinib—kidney cancer	9.35e-05	0.00051	CcSEcCtD
Mefenamic acid—Body temperature increased—Gemcitabine—kidney cancer	9.32e-05	0.000509	CcSEcCtD
Mefenamic acid—Tremor—Capecitabine—kidney cancer	9.3e-05	0.000508	CcSEcCtD
Mefenamic acid—Rash—Sunitinib—kidney cancer	9.27e-05	0.000506	CcSEcCtD
Mefenamic acid—Dermatitis—Sunitinib—kidney cancer	9.26e-05	0.000506	CcSEcCtD
Mefenamic acid—Hypotension—Paclitaxel—kidney cancer	9.23e-05	0.000504	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Capecitabine—kidney cancer	9.21e-05	0.000503	CcSEcCtD
Mefenamic acid—Headache—Sunitinib—kidney cancer	9.21e-05	0.000503	CcSEcCtD
Mefenamic acid—Asthma—Doxorubicin—kidney cancer	9.19e-05	0.000502	CcSEcCtD
Mefenamic acid—Anaemia—Capecitabine—kidney cancer	9.18e-05	0.000501	CcSEcCtD
Mefenamic acid—CYP2C9—urine—kidney cancer	9.13e-05	0.18	CbGeAlD
Mefenamic acid—Eosinophilia—Doxorubicin—kidney cancer	9.09e-05	0.000497	CcSEcCtD
Mefenamic acid—Nausea—Sorafenib—kidney cancer	9.07e-05	0.000496	CcSEcCtD
Mefenamic acid—Pancreatitis—Doxorubicin—kidney cancer	9.01e-05	0.000492	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—ABCB1—kidney cancer	8.97e-05	0.0155	CrCbGaD
Mefenamic acid—Malaise—Capecitabine—kidney cancer	8.95e-05	0.000489	CcSEcCtD
Mefenamic acid—Insomnia—Paclitaxel—kidney cancer	8.93e-05	0.000488	CcSEcCtD
Mefenamic acid—Vertigo—Capecitabine—kidney cancer	8.92e-05	0.000487	CcSEcCtD
Mefenamic acid—Asthenia—Vincristine—kidney cancer	8.92e-05	0.000487	CcSEcCtD
Mefenamic acid—Syncope—Capecitabine—kidney cancer	8.9e-05	0.000486	CcSEcCtD
Mefenamic acid—Leukopenia—Capecitabine—kidney cancer	8.89e-05	0.000485	CcSEcCtD
Mefenamic acid—Paraesthesia—Paclitaxel—kidney cancer	8.87e-05	0.000484	CcSEcCtD
Mefenamic acid—Vomiting—Dactinomycin—kidney cancer	8.85e-05	0.000483	CcSEcCtD
Mefenamic acid—Dyspnoea—Paclitaxel—kidney cancer	8.8e-05	0.000481	CcSEcCtD
Mefenamic acid—Somnolence—Paclitaxel—kidney cancer	8.78e-05	0.000479	CcSEcCtD
Mefenamic acid—Palpitations—Capecitabine—kidney cancer	8.77e-05	0.000479	CcSEcCtD
Mefenamic acid—Rash—Dactinomycin—kidney cancer	8.77e-05	0.000479	CcSEcCtD
Mefenamic acid—Nausea—Sunitinib—kidney cancer	8.73e-05	0.000477	CcSEcCtD
Mefenamic acid—Loss of consciousness—Capecitabine—kidney cancer	8.73e-05	0.000477	CcSEcCtD
Mefenamic acid—Pancytopenia—Doxorubicin—kidney cancer	8.72e-05	0.000476	CcSEcCtD
Mefenamic acid—Dyspepsia—Paclitaxel—kidney cancer	8.69e-05	0.000475	CcSEcCtD
Mefenamic acid—Salicylic acid—PTGS2—kidney cancer	8.69e-05	0.015	CrCbGaD
Mefenamic acid—Dysuria—Doxorubicin—kidney cancer	8.59e-05	0.000469	CcSEcCtD
Mefenamic acid—Decreased appetite—Paclitaxel—kidney cancer	8.58e-05	0.000469	CcSEcCtD
Mefenamic acid—Hypertension—Capecitabine—kidney cancer	8.57e-05	0.000468	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Paclitaxel—kidney cancer	8.52e-05	0.000466	CcSEcCtD
Mefenamic acid—Diarrhoea—Vincristine—kidney cancer	8.51e-05	0.000465	CcSEcCtD
Mefenamic acid—Asthenia—Gemcitabine—kidney cancer	8.46e-05	0.000462	CcSEcCtD
Mefenamic acid—Constipation—Paclitaxel—kidney cancer	8.44e-05	0.000461	CcSEcCtD
Mefenamic acid—Anxiety—Capecitabine—kidney cancer	8.42e-05	0.00046	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	8.39e-05	0.000458	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Doxorubicin—kidney cancer	8.38e-05	0.000458	CcSEcCtD
Mefenamic acid—Discomfort—Capecitabine—kidney cancer	8.35e-05	0.000456	CcSEcCtD
Mefenamic acid—Pruritus—Gemcitabine—kidney cancer	8.34e-05	0.000456	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Doxorubicin—kidney cancer	8.29e-05	0.000453	CcSEcCtD
Mefenamic acid—Dry mouth—Capecitabine—kidney cancer	8.27e-05	0.000452	CcSEcCtD
Mefenamic acid—Nausea—Dactinomycin—kidney cancer	8.27e-05	0.000451	CcSEcCtD
Mefenamic acid—Pneumonia—Doxorubicin—kidney cancer	8.24e-05	0.00045	CcSEcCtD
Mefenamic acid—Dizziness—Vincristine—kidney cancer	8.22e-05	0.000449	CcSEcCtD
Mefenamic acid—Drowsiness—Doxorubicin—kidney cancer	8.19e-05	0.000447	CcSEcCtD
Mefenamic acid—Confusional state—Capecitabine—kidney cancer	8.17e-05	0.000446	CcSEcCtD
Mefenamic acid—Feeling abnormal—Paclitaxel—kidney cancer	8.14e-05	0.000444	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	8.12e-05	0.000443	CcSEcCtD
Mefenamic acid—Oedema—Capecitabine—kidney cancer	8.1e-05	0.000443	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Paclitaxel—kidney cancer	8.07e-05	0.000441	CcSEcCtD
Mefenamic acid—Diarrhoea—Gemcitabine—kidney cancer	8.07e-05	0.000441	CcSEcCtD
Mefenamic acid—Renal failure—Doxorubicin—kidney cancer	8.05e-05	0.00044	CcSEcCtD
Mefenamic acid—Infection—Capecitabine—kidney cancer	8.05e-05	0.00044	CcSEcCtD
Mefenamic acid—Stomatitis—Doxorubicin—kidney cancer	7.98e-05	0.000436	CcSEcCtD
Mefenamic acid—Jaundice—Doxorubicin—kidney cancer	7.98e-05	0.000436	CcSEcCtD
Mefenamic acid—Shock—Capecitabine—kidney cancer	7.97e-05	0.000435	CcSEcCtD
Mefenamic acid—Conjunctivitis—Doxorubicin—kidney cancer	7.96e-05	0.000435	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Capecitabine—kidney cancer	7.93e-05	0.000433	CcSEcCtD
Mefenamic acid—Tachycardia—Capecitabine—kidney cancer	7.91e-05	0.000432	CcSEcCtD
Mefenamic acid—Vomiting—Vincristine—kidney cancer	7.9e-05	0.000432	CcSEcCtD
Mefenamic acid—Skin disorder—Capecitabine—kidney cancer	7.87e-05	0.00043	CcSEcCtD
Mefenamic acid—Urticaria—Paclitaxel—kidney cancer	7.84e-05	0.000428	CcSEcCtD
Mefenamic acid—Rash—Vincristine—kidney cancer	7.84e-05	0.000428	CcSEcCtD
Mefenamic acid—Dermatitis—Vincristine—kidney cancer	7.83e-05	0.000428	CcSEcCtD
Mefenamic acid—Haematuria—Doxorubicin—kidney cancer	7.81e-05	0.000426	CcSEcCtD
Mefenamic acid—Body temperature increased—Paclitaxel—kidney cancer	7.81e-05	0.000426	CcSEcCtD
Mefenamic acid—Abdominal pain—Paclitaxel—kidney cancer	7.81e-05	0.000426	CcSEcCtD
Mefenamic acid—Headache—Vincristine—kidney cancer	7.79e-05	0.000425	CcSEcCtD
Mefenamic acid—Diclofenac—PTGS2—kidney cancer	7.78e-05	0.0135	CrCbGaD
Mefenamic acid—Anorexia—Capecitabine—kidney cancer	7.72e-05	0.000422	CcSEcCtD
Mefenamic acid—Agranulocytosis—Doxorubicin—kidney cancer	7.64e-05	0.000417	CcSEcCtD
Mefenamic acid—Flurbiprofen—PTGS2—kidney cancer	7.62e-05	0.0132	CrCbGaD
Mefenamic acid—Hypotension—Capecitabine—kidney cancer	7.57e-05	0.000414	CcSEcCtD
Mefenamic acid—Vomiting—Gemcitabine—kidney cancer	7.5e-05	0.00041	CcSEcCtD
Mefenamic acid—Rash—Gemcitabine—kidney cancer	7.44e-05	0.000406	CcSEcCtD
Mefenamic acid—Dermatitis—Gemcitabine—kidney cancer	7.43e-05	0.000406	CcSEcCtD
Mefenamic acid—Haemoglobin—Doxorubicin—kidney cancer	7.39e-05	0.000404	CcSEcCtD
Mefenamic acid—Headache—Gemcitabine—kidney cancer	7.39e-05	0.000404	CcSEcCtD
Mefenamic acid—Salicylic acid—ABCB1—kidney cancer	7.39e-05	0.0128	CrCbGaD
Mefenamic acid—Nausea—Vincristine—kidney cancer	7.38e-05	0.000403	CcSEcCtD
Mefenamic acid—Haemorrhage—Doxorubicin—kidney cancer	7.35e-05	0.000402	CcSEcCtD
Mefenamic acid—Hepatitis—Doxorubicin—kidney cancer	7.35e-05	0.000402	CcSEcCtD
Mefenamic acid—Insomnia—Capecitabine—kidney cancer	7.33e-05	0.0004	CcSEcCtD
Mefenamic acid—Paraesthesia—Capecitabine—kidney cancer	7.28e-05	0.000397	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Doxorubicin—kidney cancer	7.26e-05	0.000397	CcSEcCtD
Mefenamic acid—Dyspnoea—Capecitabine—kidney cancer	7.22e-05	0.000395	CcSEcCtD
Mefenamic acid—Urethral disorder—Doxorubicin—kidney cancer	7.21e-05	0.000394	CcSEcCtD
Mefenamic acid—Dyspepsia—Capecitabine—kidney cancer	7.13e-05	0.00039	CcSEcCtD
Mefenamic acid—Asthenia—Paclitaxel—kidney cancer	7.08e-05	0.000387	CcSEcCtD
Mefenamic acid—Decreased appetite—Capecitabine—kidney cancer	7.04e-05	0.000385	CcSEcCtD
Mefenamic acid—Nausea—Gemcitabine—kidney cancer	7.01e-05	0.000383	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Capecitabine—kidney cancer	7e-05	0.000382	CcSEcCtD
Mefenamic acid—Pruritus—Paclitaxel—kidney cancer	6.99e-05	0.000382	CcSEcCtD
Mefenamic acid—Erythema multiforme—Doxorubicin—kidney cancer	6.95e-05	0.00038	CcSEcCtD
Mefenamic acid—Constipation—Capecitabine—kidney cancer	6.93e-05	0.000378	CcSEcCtD
Mefenamic acid—Ketoprofen—PTGS2—kidney cancer	6.89e-05	0.0119	CrCbGaD
Mefenamic acid—Tinnitus—Doxorubicin—kidney cancer	6.85e-05	0.000374	CcSEcCtD
Mefenamic acid—Diarrhoea—Paclitaxel—kidney cancer	6.76e-05	0.000369	CcSEcCtD
Mefenamic acid—Feeling abnormal—Capecitabine—kidney cancer	6.68e-05	0.000365	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Capecitabine—kidney cancer	6.63e-05	0.000362	CcSEcCtD
Mefenamic acid—Diclofenac—ABCB1—kidney cancer	6.61e-05	0.0115	CrCbGaD
Mefenamic acid—Arrhythmia—Doxorubicin—kidney cancer	6.57e-05	0.000359	CcSEcCtD
Mefenamic acid—Dizziness—Paclitaxel—kidney cancer	6.53e-05	0.000357	CcSEcCtD
Mefenamic acid—Alopecia—Doxorubicin—kidney cancer	6.5e-05	0.000355	CcSEcCtD
Mefenamic acid—Mental disorder—Doxorubicin—kidney cancer	6.44e-05	0.000352	CcSEcCtD
Mefenamic acid—Urticaria—Capecitabine—kidney cancer	6.44e-05	0.000352	CcSEcCtD
Mefenamic acid—Body temperature increased—Capecitabine—kidney cancer	6.41e-05	0.00035	CcSEcCtD
Mefenamic acid—Abdominal pain—Capecitabine—kidney cancer	6.41e-05	0.00035	CcSEcCtD
Mefenamic acid—AKR1C3—nephron tubule—kidney cancer	6.34e-05	0.125	CbGeAlD
Mefenamic acid—Flatulence—Doxorubicin—kidney cancer	6.31e-05	0.000344	CcSEcCtD
Mefenamic acid—Tension—Doxorubicin—kidney cancer	6.28e-05	0.000343	CcSEcCtD
Mefenamic acid—Vomiting—Paclitaxel—kidney cancer	6.28e-05	0.000343	CcSEcCtD
Mefenamic acid—Rash—Paclitaxel—kidney cancer	6.23e-05	0.00034	CcSEcCtD
Mefenamic acid—Dermatitis—Paclitaxel—kidney cancer	6.22e-05	0.00034	CcSEcCtD
Mefenamic acid—Nervousness—Doxorubicin—kidney cancer	6.22e-05	0.00034	CcSEcCtD
Mefenamic acid—Headache—Paclitaxel—kidney cancer	6.19e-05	0.000338	CcSEcCtD
Mefenamic acid—Vision blurred—Doxorubicin—kidney cancer	6.03e-05	0.000329	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Doxorubicin—kidney cancer	5.94e-05	0.000324	CcSEcCtD
Mefenamic acid—Anaemia—Doxorubicin—kidney cancer	5.92e-05	0.000323	CcSEcCtD
Mefenamic acid—Nausea—Paclitaxel—kidney cancer	5.87e-05	0.00032	CcSEcCtD
Mefenamic acid—Asthenia—Capecitabine—kidney cancer	5.81e-05	0.000318	CcSEcCtD
Mefenamic acid—Malaise—Doxorubicin—kidney cancer	5.77e-05	0.000315	CcSEcCtD
Mefenamic acid—Vertigo—Doxorubicin—kidney cancer	5.75e-05	0.000314	CcSEcCtD
Mefenamic acid—Syncope—Doxorubicin—kidney cancer	5.74e-05	0.000313	CcSEcCtD
Mefenamic acid—Pruritus—Capecitabine—kidney cancer	5.73e-05	0.000313	CcSEcCtD
Mefenamic acid—Leukopenia—Doxorubicin—kidney cancer	5.73e-05	0.000313	CcSEcCtD
Mefenamic acid—Palpitations—Doxorubicin—kidney cancer	5.66e-05	0.000309	CcSEcCtD
Mefenamic acid—Loss of consciousness—Doxorubicin—kidney cancer	5.63e-05	0.000307	CcSEcCtD
Mefenamic acid—Convulsion—Doxorubicin—kidney cancer	5.55e-05	0.000303	CcSEcCtD
Mefenamic acid—Diarrhoea—Capecitabine—kidney cancer	5.54e-05	0.000303	CcSEcCtD
Mefenamic acid—Hypertension—Doxorubicin—kidney cancer	5.53e-05	0.000302	CcSEcCtD
Mefenamic acid—Anxiety—Doxorubicin—kidney cancer	5.43e-05	0.000297	CcSEcCtD
Mefenamic acid—AKR1C3—cortex of kidney—kidney cancer	5.43e-05	0.107	CbGeAlD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	5.41e-05	0.000296	CcSEcCtD
Mefenamic acid—Discomfort—Doxorubicin—kidney cancer	5.38e-05	0.000294	CcSEcCtD
Mefenamic acid—Dizziness—Capecitabine—kidney cancer	5.36e-05	0.000293	CcSEcCtD
Mefenamic acid—Dry mouth—Doxorubicin—kidney cancer	5.33e-05	0.000291	CcSEcCtD
Mefenamic acid—Confusional state—Doxorubicin—kidney cancer	5.27e-05	0.000288	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Doxorubicin—kidney cancer	5.22e-05	0.000285	CcSEcCtD
Mefenamic acid—Oedema—Doxorubicin—kidney cancer	5.22e-05	0.000285	CcSEcCtD
Mefenamic acid—Infection—Doxorubicin—kidney cancer	5.19e-05	0.000283	CcSEcCtD
Mefenamic acid—AKR1C3—cardiac atrium—kidney cancer	5.16e-05	0.102	CbGeAlD
Mefenamic acid—Vomiting—Capecitabine—kidney cancer	5.15e-05	0.000281	CcSEcCtD
Mefenamic acid—Shock—Doxorubicin—kidney cancer	5.14e-05	0.000281	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Doxorubicin—kidney cancer	5.11e-05	0.000279	CcSEcCtD
Mefenamic acid—Rash—Capecitabine—kidney cancer	5.11e-05	0.000279	CcSEcCtD
Mefenamic acid—Dermatitis—Capecitabine—kidney cancer	5.1e-05	0.000279	CcSEcCtD
Mefenamic acid—Tachycardia—Doxorubicin—kidney cancer	5.1e-05	0.000278	CcSEcCtD
Mefenamic acid—Headache—Capecitabine—kidney cancer	5.08e-05	0.000277	CcSEcCtD
Mefenamic acid—Skin disorder—Doxorubicin—kidney cancer	5.07e-05	0.000277	CcSEcCtD
Mefenamic acid—Anorexia—Doxorubicin—kidney cancer	4.98e-05	0.000272	CcSEcCtD
Mefenamic acid—Hypotension—Doxorubicin—kidney cancer	4.88e-05	0.000267	CcSEcCtD
Mefenamic acid—Nausea—Capecitabine—kidney cancer	4.81e-05	0.000263	CcSEcCtD
Mefenamic acid—Insomnia—Doxorubicin—kidney cancer	4.72e-05	0.000258	CcSEcCtD
Mefenamic acid—Paraesthesia—Doxorubicin—kidney cancer	4.69e-05	0.000256	CcSEcCtD
Mefenamic acid—Dyspnoea—Doxorubicin—kidney cancer	4.66e-05	0.000254	CcSEcCtD
Mefenamic acid—Somnolence—Doxorubicin—kidney cancer	4.64e-05	0.000254	CcSEcCtD
Mefenamic acid—Dyspepsia—Doxorubicin—kidney cancer	4.6e-05	0.000251	CcSEcCtD
Mefenamic acid—Decreased appetite—Doxorubicin—kidney cancer	4.54e-05	0.000248	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.51e-05	0.000246	CcSEcCtD
Mefenamic acid—Constipation—Doxorubicin—kidney cancer	4.47e-05	0.000244	CcSEcCtD
Mefenamic acid—Feeling abnormal—Doxorubicin—kidney cancer	4.3e-05	0.000235	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Doxorubicin—kidney cancer	4.27e-05	0.000233	CcSEcCtD
Mefenamic acid—Urticaria—Doxorubicin—kidney cancer	4.15e-05	0.000227	CcSEcCtD
Mefenamic acid—Abdominal pain—Doxorubicin—kidney cancer	4.13e-05	0.000226	CcSEcCtD
Mefenamic acid—Body temperature increased—Doxorubicin—kidney cancer	4.13e-05	0.000226	CcSEcCtD
Mefenamic acid—Asthenia—Doxorubicin—kidney cancer	3.75e-05	0.000205	CcSEcCtD
Mefenamic acid—Pruritus—Doxorubicin—kidney cancer	3.7e-05	0.000202	CcSEcCtD
Mefenamic acid—Diarrhoea—Doxorubicin—kidney cancer	3.57e-05	0.000195	CcSEcCtD
Mefenamic acid—Dizziness—Doxorubicin—kidney cancer	3.45e-05	0.000189	CcSEcCtD
Mefenamic acid—Vomiting—Doxorubicin—kidney cancer	3.32e-05	0.000181	CcSEcCtD
Mefenamic acid—Rash—Doxorubicin—kidney cancer	3.29e-05	0.00018	CcSEcCtD
Mefenamic acid—Dermatitis—Doxorubicin—kidney cancer	3.29e-05	0.00018	CcSEcCtD
Mefenamic acid—Headache—Doxorubicin—kidney cancer	3.27e-05	0.000179	CcSEcCtD
Mefenamic acid—Nausea—Doxorubicin—kidney cancer	3.1e-05	0.000169	CcSEcCtD
Mefenamic acid—CYP2C8—renal system—kidney cancer	2.51e-05	0.0497	CbGeAlD
Mefenamic acid—CYP2C8—kidney—kidney cancer	2.43e-05	0.048	CbGeAlD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.39e-05	0.000376	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GLIPR1—kidney cancer	2.39e-05	0.000375	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPAT—kidney cancer	2.39e-05	0.000375	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PDHB—kidney cancer	2.39e-05	0.000375	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CYP1A1—kidney cancer	2.38e-05	0.000374	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CA9—kidney cancer	2.38e-05	0.000374	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CDKN1B—kidney cancer	2.38e-05	0.000374	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.38e-05	0.000374	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—POMC—kidney cancer	2.38e-05	0.000373	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ST3GAL2—kidney cancer	2.37e-05	0.000373	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.37e-05	0.000373	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.36e-05	0.00037	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.36e-05	0.00037	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.34e-05	0.000367	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.33e-05	0.000366	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALDH1A1—kidney cancer	2.32e-05	0.000364	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—KIT—kidney cancer	2.32e-05	0.000364	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—APC—kidney cancer	2.32e-05	0.000364	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—kidney cancer	2.3e-05	0.000362	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.3e-05	0.000361	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CTNNB1—kidney cancer	2.25e-05	0.000353	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CCBL1—kidney cancer	2.24e-05	0.000352	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—APC—kidney cancer	2.23e-05	0.00035	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—KIT—kidney cancer	2.23e-05	0.00035	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IGF2—kidney cancer	2.23e-05	0.00035	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PGK1—kidney cancer	2.23e-05	0.000349	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC5A3—kidney cancer	2.23e-05	0.000349	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APRT—kidney cancer	2.22e-05	0.000349	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—FH—kidney cancer	2.22e-05	0.000349	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN2B—kidney cancer	2.22e-05	0.000348	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—POMC—kidney cancer	2.21e-05	0.000347	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PTEN—kidney cancer	2.19e-05	0.000344	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—LDHB—kidney cancer	2.18e-05	0.000343	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—BRAF—kidney cancer	2.18e-05	0.000342	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.17e-05	0.000341	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IGF1R—kidney cancer	2.15e-05	0.000338	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTGS2—kidney cancer	2.11e-05	0.000331	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—BRAF—kidney cancer	2.1e-05	0.000329	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GPC3—kidney cancer	2.09e-05	0.000328	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.07e-05	0.000326	CbGpPWpGaD
Mefenamic acid—PTGS1—renal system—kidney cancer	2.04e-05	0.0403	CbGeAlD
Mefenamic acid—CYP2C8—Metabolism—CA2—kidney cancer	2.03e-05	0.000319	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.03e-05	0.000318	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CRABP1—kidney cancer	2.03e-05	0.000318	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALAD—kidney cancer	1.98e-05	0.000311	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RPL14—kidney cancer	1.97e-05	0.00031	CbGpPWpGaD
Mefenamic acid—PTGS1—kidney—kidney cancer	1.97e-05	0.039	CbGeAlD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.96e-05	0.000308	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.96e-05	0.000307	CbGpPWpGaD
Mefenamic acid—PTGS2—renal system—kidney cancer	1.95e-05	0.0385	CbGeAlD
Mefenamic acid—CYP2C9—Metabolism—PPAT—kidney cancer	1.94e-05	0.000305	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.94e-05	0.000305	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.93e-05	0.000303	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.92e-05	0.000301	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.91e-05	0.0003	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.9e-05	0.000298	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CA9—kidney cancer	1.89e-05	0.000297	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.89e-05	0.000297	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ITPR2—kidney cancer	1.88e-05	0.000296	CbGpPWpGaD
Mefenamic acid—PTGS2—kidney—kidney cancer	1.88e-05	0.0372	CbGeAlD
Mefenamic acid—AKR1C1—Disease—MAPK3—kidney cancer	1.87e-05	0.000294	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.87e-05	0.000293	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.85e-05	0.00029	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTEN—kidney cancer	1.84e-05	0.000288	CbGpPWpGaD
Mefenamic acid—PTGS1—cardiac atrium—kidney cancer	1.83e-05	0.0361	CbGeAlD
Mefenamic acid—AKR1C1—Disease—MYC—kidney cancer	1.82e-05	0.000286	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—RAF1—kidney cancer	1.82e-05	0.000286	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—RELA—kidney cancer	1.81e-05	0.000285	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PGK1—kidney cancer	1.81e-05	0.000284	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.81e-05	0.000284	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APRT—kidney cancer	1.81e-05	0.000284	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—FH—kidney cancer	1.81e-05	0.000284	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ERBB2—kidney cancer	1.8e-05	0.000283	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ITPR2—kidney cancer	1.79e-05	0.00028	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MAPK1—kidney cancer	1.78e-05	0.00028	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MTOR—kidney cancer	1.78e-05	0.000279	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—POMC—kidney cancer	1.78e-05	0.000279	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LDHB—kidney cancer	1.78e-05	0.000279	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HIF1A—kidney cancer	1.77e-05	0.000278	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TSC2—kidney cancer	1.77e-05	0.000278	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.77e-05	0.000277	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PIK3CA—kidney cancer	1.77e-05	0.000277	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.76e-05	0.000277	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—RAF1—kidney cancer	1.75e-05	0.000275	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.74e-05	0.000273	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ERBB2—kidney cancer	1.73e-05	0.000272	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ACHE—kidney cancer	1.72e-05	0.00027	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTT1—kidney cancer	1.72e-05	0.00027	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MTOR—kidney cancer	1.71e-05	0.000268	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CD4—kidney cancer	1.71e-05	0.000268	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GPC3—kidney cancer	1.7e-05	0.000267	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KDR—kidney cancer	1.69e-05	0.000266	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—kidney cancer	1.69e-05	0.000266	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—KRAS—kidney cancer	1.68e-05	0.000264	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CDKN1B—kidney cancer	1.67e-05	0.000262	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA2—kidney cancer	1.65e-05	0.00026	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL2—kidney cancer	1.63e-05	0.000256	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SCARB1—kidney cancer	1.63e-05	0.000255	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.62e-05	0.000254	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALAD—kidney cancer	1.61e-05	0.000253	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CRABP1—kidney cancer	1.61e-05	0.000253	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CDKN1B—kidney cancer	1.6e-05	0.000252	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCND1—kidney cancer	1.59e-05	0.00025	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—JUN—kidney cancer	1.59e-05	0.000249	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PSMD7—kidney cancer	1.58e-05	0.000248	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CTNNB1—kidney cancer	1.58e-05	0.000247	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.57e-05	0.000247	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.57e-05	0.000246	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APC—kidney cancer	1.56e-05	0.000245	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KIT—kidney cancer	1.56e-05	0.000245	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PIK3CA—kidney cancer	1.55e-05	0.000243	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CA9—kidney cancer	1.54e-05	0.000242	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.54e-05	0.000241	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PTEN—kidney cancer	1.54e-05	0.000241	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CTNNB1—kidney cancer	1.51e-05	0.000238	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.5e-05	0.000236	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—BCHE—kidney cancer	1.5e-05	0.000235	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PSMD7—kidney cancer	1.5e-05	0.000235	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ITPR2—kidney cancer	1.5e-05	0.000235	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—POMC—kidney cancer	1.49e-05	0.000233	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SLC5A5—kidney cancer	1.48e-05	0.000232	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTEN—kidney cancer	1.48e-05	0.000232	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.47e-05	0.000231	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PGK1—kidney cancer	1.47e-05	0.000231	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—BRAF—kidney cancer	1.47e-05	0.00023	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LDHB—kidney cancer	1.45e-05	0.000227	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SLC2A1—kidney cancer	1.43e-05	0.000224	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—kidney cancer	1.42e-05	0.000223	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—kidney cancer	1.39e-05	0.000218	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.39e-05	0.000218	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.38e-05	0.000217	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ACHE—kidney cancer	1.36e-05	0.000214	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTT1—kidney cancer	1.36e-05	0.000214	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SLC2A1—kidney cancer	1.35e-05	0.000213	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—JUNB—kidney cancer	1.34e-05	0.000211	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK3—kidney cancer	1.31e-05	0.000206	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CRABP1—kidney cancer	1.31e-05	0.000206	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CA—kidney cancer	1.3e-05	0.000203	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SCARB1—kidney cancer	1.29e-05	0.000203	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PTGS1—kidney cancer	1.28e-05	0.000201	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MYC—kidney cancer	1.28e-05	0.0002	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MAPK3—kidney cancer	1.26e-05	0.000198	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PSMD7—kidney cancer	1.25e-05	0.000197	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA9—kidney cancer	1.25e-05	0.000197	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK1—kidney cancer	1.25e-05	0.000196	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTEN—kidney cancer	1.24e-05	0.000194	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MYC—kidney cancer	1.23e-05	0.000193	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RAF1—kidney cancer	1.23e-05	0.000192	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.22e-05	0.000192	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RELA—kidney cancer	1.22e-05	0.000192	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ITPR2—kidney cancer	1.22e-05	0.000191	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ERBB2—kidney cancer	1.21e-05	0.00019	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.21e-05	0.00019	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MAPK1—kidney cancer	1.2e-05	0.000188	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MTOR—kidney cancer	1.2e-05	0.000188	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTP1—kidney cancer	1.19e-05	0.000187	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—BCHE—kidney cancer	1.19e-05	0.000187	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—KRAS—kidney cancer	1.18e-05	0.000185	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC5A5—kidney cancer	1.17e-05	0.000184	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC2A1—kidney cancer	1.13e-05	0.000178	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—KRAS—kidney cancer	1.13e-05	0.000178	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ABCB1—kidney cancer	1.13e-05	0.000177	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN1B—kidney cancer	1.12e-05	0.000176	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.12e-05	0.000176	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ACHE—kidney cancer	1.11e-05	0.000174	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTT1—kidney cancer	1.11e-05	0.000174	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL2—kidney cancer	1.1e-05	0.000172	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTM1—kidney cancer	1.09e-05	0.000172	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN2B—kidney cancer	1.09e-05	0.000172	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CA—kidney cancer	1.08e-05	0.00017	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCND1—kidney cancer	1.07e-05	0.000168	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—JUN—kidney cancer	1.07e-05	0.000168	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CRABP1—kidney cancer	1.07e-05	0.000167	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CTNNB1—kidney cancer	1.06e-05	0.000167	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SCARB1—kidney cancer	1.05e-05	0.000165	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—kidney cancer	1.05e-05	0.000165	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CA—kidney cancer	1.04e-05	0.000164	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS1—kidney cancer	1.04e-05	0.000163	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP1A1—kidney cancer	1.04e-05	0.000163	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTEN—kidney cancer	1.03e-05	0.000162	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PSMD7—kidney cancer	1.02e-05	0.00016	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ITPR2—kidney cancer	9.91e-06	0.000156	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—BCHE—kidney cancer	9.67e-06	0.000152	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.59e-06	0.000151	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC5A5—kidney cancer	9.55e-06	0.00015	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTP1—kidney cancer	9.45e-06	0.000148	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—kidney cancer	9.34e-06	0.000147	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC2A1—kidney cancer	9.22e-06	0.000145	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.13e-06	0.000143	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTT1—kidney cancer	9.03e-06	0.000142	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ACHE—kidney cancer	9.03e-06	0.000142	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ABCB1—kidney cancer	8.95e-06	0.000141	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.95e-06	0.000141	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK3—kidney cancer	8.83e-06	0.000139	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HIF1A—kidney cancer	8.74e-06	0.000137	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TSC2—kidney cancer	8.72e-06	0.000137	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CA—kidney cancer	8.72e-06	0.000137	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTM1—kidney cancer	8.69e-06	0.000136	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MYC—kidney cancer	8.59e-06	0.000135	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SCARB1—kidney cancer	8.55e-06	0.000134	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.52e-06	0.000134	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS1—kidney cancer	8.46e-06	0.000133	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK1—kidney cancer	8.4e-06	0.000132	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PSMD7—kidney cancer	8.3e-06	0.00013	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP1A1—kidney cancer	8.24e-06	0.000129	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KRAS—kidney cancer	7.94e-06	0.000125	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—BCHE—kidney cancer	7.87e-06	0.000124	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.8e-06	0.000123	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC5A5—kidney cancer	7.77e-06	0.000122	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—POMC—kidney cancer	7.74e-06	0.000121	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APC—kidney cancer	7.7e-06	0.000121	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—KIT—kidney cancer	7.7e-06	0.000121	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTP1—kidney cancer	7.69e-06	0.000121	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC2A1—kidney cancer	7.51e-06	0.000118	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CA—kidney cancer	7.29e-06	0.000114	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.28e-06	0.000114	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ABCB1—kidney cancer	7.28e-06	0.000114	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—BRAF—kidney cancer	7.24e-06	0.000114	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTM1—kidney cancer	7.07e-06	0.000111	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—kidney cancer	7.05e-06	0.000111	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.77e-06	0.000106	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP1A1—kidney cancer	6.7e-06	0.000105	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.35e-06	9.97e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTP1—kidney cancer	6.26e-06	9.83e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—kidney cancer	6.17e-06	9.69e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—POMC—kidney cancer	6.14e-06	9.64e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RAF1—kidney cancer	6.05e-06	9.49e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ERBB2—kidney cancer	5.98e-06	9.39e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ABCB1—kidney cancer	5.93e-06	9.31e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MTOR—kidney cancer	5.9e-06	9.27e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD4—kidney cancer	5.89e-06	9.25e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTM1—kidney cancer	5.75e-06	9.03e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN1B—kidney cancer	5.54e-06	8.7e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.51e-06	8.64e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP1A1—kidney cancer	5.45e-06	8.56e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTEN—kidney cancer	5.38e-06	8.45e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CTNNB1—kidney cancer	5.23e-06	8.22e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PTEN—kidney cancer	5.1e-06	8.01e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—POMC—kidney cancer	5e-06	7.85e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.48e-06	7.04e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MAPK3—kidney cancer	4.36e-06	6.84e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PTEN—kidney cancer	4.27e-06	6.71e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MYC—kidney cancer	4.24e-06	6.66e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MAPK1—kidney cancer	4.15e-06	6.51e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—POMC—kidney cancer	4.07e-06	6.39e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—kidney cancer	3.99e-06	6.26e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—KRAS—kidney cancer	3.92e-06	6.15e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CA—kidney cancer	3.8e-06	5.96e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CA—kidney cancer	3.6e-06	5.65e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTEN—kidney cancer	3.48e-06	5.46e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—kidney cancer	3.24e-06	5.09e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CA—kidney cancer	3.01e-06	4.73e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTEN—kidney cancer	2.83e-06	4.44e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.45e-06	3.85e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CA—kidney cancer	2e-06	3.13e-05	CbGpPWpGaD
